Peers of Vitaspring Biomedical Co. Ltd (VSBC)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month free cash flow. Values the entire business on cash available after reinvestment.
Latest EV/FCF
1044.32x
As of Oct 8, 2026
Beyond EV/FCF, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/FCF |
|---|---|
| Oct 8, 2026 | 1044.32x |
| Feb 12, 2026 | -208.72x |
| Jan 27, 2026 | -3835.27x |
| Mar 5, 2025 | 3026.75x |
| Mar 4, 2025 | 3026.75x |
| Feb 26, 2025 | 605.35x |
| Feb 19, 2025 | 544.81x |
| Jan 28, 2025 | 427.13x |
EV/FCF = Enterprise Value / Free Cash Flow (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/FCF is especially insightful for capital-intensive businesses.
Read the general EV/FCF definition, formula, and analyst usage guide.
EV/FCF guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison